Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
26 March 2025
| Name: | AVT PLASMA LIMITED (AVT) | |||||||||||||||
| Date of Listing: | 18 October 1994 | |||||||||||||||
| Date of Delisting: | 29 August 2007 | |||||||||||||||
| Former Names: |
|
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 29 August 2007.Legal Status:
ACN: 065 824 302ABN: 72 065 824 302
Registration Date: 27 July 1994
Deregistration Date: 03 May 2009
Capital Gains Tax (CGT) Status:
This entity was deregistered on 03 May 2009. Deregistration is a Capital Gains Tax Event. In our opinion you are entitled to crystallise any capital loss in the tax year that deregistration occurs providing you have not previously done so. If you did not crystallise your loss in the tax year the entity was deregistered, you may seek to re-open that year’s assessment but anyway should seek professional advice as to how best to proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| AVT PLASMA LIMITED | 22/04/2005 | |
| AVT BIOPLASMA LIMITED | 20/09/2004 | 22/04/2005 |
| AVT HOLDINGS LIMITED | 10/08/2001 | 20/09/2004 |
| AUSTRALIAN VACCINE TECHNOLOGIES LIMITED | 31/01/2000 | 10/08/2001 |
| NEPTUNUS INTERNATIONAL HOLDINGS LIMITED | 31/01/2000 |
REGISTRY:
Computershare Sydney
6 Hope St Ermington NSW 2115
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail
company is deregistered and has therefore ceased to exist | 03/05/2009 |
Strike-Off Action is in Progress | 03/04/2009 |
a liquidator has apparently been appointed following a Court Order to Wind Up the Company And Appoint a Liquidator (we would appreciate advice to admin@delisted.com.au from the liquidator or anyone having knowledge of the liquidator) | 03/07/2008 |
delisted following failure to pay listing fee | 29/08/2007 |
it is unbelievable that a listed company's directors (Zhang Simin, Ken Baxter, Gregory Willis, Peter Nie Zhi Hua and Jinsong (Sophie) Wang can have so little regard for their shareholders that there has been no advice to the market of the situation with this company since October 2006 - particularly in the light of the assurances provided in that update - there is a complete absence of regulation at this end of the market place, to the extent that all shareholders should be advised to avoid it | 09/08/2007 |
company advises it has undertaken a fundraising process to institutional investors which will bring investments from Neptunus Pharmaceuticals USA and other investors into AVT - A report including the audited financial statements will be distributed to all shareholders and made available to all potential investors (when?) - The draft of the explanatory memorandum and the announcement of the shareholders' meeting to discuss and vote upon the resolutions for the fund raisings, the restructuring of the AVT Board of Directors and other company business is near completion and will be distributed to all AVT shareholders in the coming weeks | 20/10/2006 |
the appointment of Justin Leung and the big plans announced on 28 November 2005 appear to have come to nothing - there has been no release to the market since - it continues to astonish us that a board of directors can have so little regard for their shareholders ie, the owners of the company (and that the regulator lets them get away with it) | 06/09/2006 |
a Notification of Dismissal of Application For Winding Up Order is lodged with ASIC | 02/03/2006 |
a Notification of Filing of Application For Winding Up Order is lodged with ASIC | 01/02/2006 |
amends agreement with Neptunus Pharmaceuticals USA Inc and announces the appointment of Mr Justin Leung as CEO | 28/11/2005 |
cash flow report shows a deficit at operating level of about $10k for the month ended 31 October 2005 | 22/11/2005 |
cash flow report shows a deficit at operating level of about $48k for the quarter ended 30 September 2005 | 03/11/2005 |
we understand that a liquidator has not yet been appointed and that directors are endeavouring to resolve the issues and hopefully save the company - essentially directors have declared that the company is insolvent and therefore operations have been curtailed and it is no longer incurring debt - it is likely the situation will be resolved one way or the other over the next few weeks (rather than months) | 20/07/2005 |
shares suspended from quotation following the decision to appoint a liquidator and wind up the company, pursuant to Hong Kong law - this decision follows advice from Neptunus Pharmaceuticals Inc (USA) that it will not subscribe US$550,000 as it is obliged to do under a Subscription Agreement - this move unfortunately does not augur well for shareholders | 05/07/2005 |
name changed from AVT Bioplasma Limited | 22/04/2005 |
company is deregistered and has therefore ceased to exist | 03/05/2009 |
Strike-Off Action is in Progress | 03/04/2009 |
a liquidator has apparently been appointed following a Court Order to Wind Up the Company And Appoint a Liquidator (we would appreciate advice to admin@delisted.com.au from the liquidator or anyone having knowledge of the liquidator) | 03/07/2008 |
delisted following failure to pay listing fee | 29/08/2007 |
it is unbelievable that a listed company's directors (Zhang Simin, Ken Baxter, Gregory Willis, Peter Nie Zhi Hua and Jinsong (Sophie) Wang can have so little regard for their shareholders that there has been no advice to the market of the situation with this company since October 2006 - particularly in the light of the assurances provided in that update - there is a complete absence of regulation at this end of the market place, to the extent that all shareholders should be advised to avoid it | 09/08/2007 |
company advises it has undertaken a fundraising process to institutional investors which will bring investments from Neptunus Pharmaceuticals USA and other investors into AVT - A report including the audited financial statements will be distributed to all shareholders and made available to all potential investors (when?) - The draft of the explanatory memorandum and the announcement of the shareholders' meeting to discuss and vote upon the resolutions for the fund raisings, the restructuring of the AVT Board of Directors and other company business is near completion and will be distributed to all AVT shareholders in the coming weeks | 20/10/2006 |
the appointment of Justin Leung and the big plans announced on 28 November 2005 appear to have come to nothing - there has been no release to the market since - it continues to astonish us that a board of directors can have so little regard for their shareholders ie, the owners of the company (and that the regulator lets them get away with it) | 06/09/2006 |
a Notification of Dismissal of Application For Winding Up Order is lodged with ASIC | 02/03/2006 |
a Notification of Filing of Application For Winding Up Order is lodged with ASIC | 01/02/2006 |
amends agreement with Neptunus Pharmaceuticals USA Inc and announces the appointment of Mr Justin Leung as CEO | 28/11/2005 |
cash flow report shows a deficit at operating level of about $10k for the month ended 31 October 2005 | 22/11/2005 |
cash flow report shows a deficit at operating level of about $48k for the quarter ended 30 September 2005 | 03/11/2005 |
we understand that a liquidator has not yet been appointed and that directors are endeavouring to resolve the issues and hopefully save the company - essentially directors have declared that the company is insolvent and therefore operations have been curtailed and it is no longer incurring debt - it is likely the situation will be resolved one way or the other over the next few weeks (rather than months) | 20/07/2005 |
shares suspended from quotation following the decision to appoint a liquidator and wind up the company, pursuant to Hong Kong law - this decision follows advice from Neptunus Pharmaceuticals Inc (USA) that it will not subscribe US$550,000 as it is obliged to do under a Subscription Agreement - this move unfortunately does not augur well for shareholders | 05/07/2005 |
name changed from AVT Bioplasma Limited | 22/04/2005 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Zhang Simin | Chairman | |
| Peter Nie | Director | |
| Sophie Wang | Director | |
| Gregory Willis | Company Secretary |
Date of first appointment, title may have changed.
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
